Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Incyte ROA 2010-2025 | INCY

Current and historical return on assets (ROA) values for Incyte (INCY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Incyte ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $0.02B $5.75B 0.38%
2024-12-31 $0.03B $5.44B 0.58%
2024-09-30 $0.03B $5.01B 0.54%
2024-06-30 $0.10B $4.66B 1.55%
2024-03-31 $0.75B $7.14B 11.25%
2023-12-31 $0.60B $6.78B 9.50%
2023-09-30 $0.43B $6.39B 7.01%
2023-06-30 $0.37B $6.21B 6.29%
2023-03-31 $0.32B $5.80B 5.77%
2022-12-31 $0.34B $5.84B 6.26%
2022-09-30 $0.88B $5.51B 16.83%
2022-06-30 $0.95B $5.32B 19.38%
2022-03-31 $0.93B $5.05B 20.63%
2021-12-31 $0.95B $4.93B 22.73%
2021-09-30 $0.54B $4.20B 13.96%
2021-06-30 $0.34B $3.91B 9.37%
2021-03-31 $0.48B $3.66B 13.94%
2020-12-31 $-0.30B $3.56B -9.23%
2020-09-30 $-0.34B $3.31B -10.55%
2020-06-30 $-0.19B $3.21B -6.09%
2020-03-31 $-0.38B $2.75B -12.22%
2019-12-31 $0.45B $3.43B 14.45%
2019-09-30 $0.40B $3.22B 13.98%
2019-06-30 $0.31B $2.95B 11.23%
2019-03-31 $0.25B $2.75B 9.77%
2018-12-31 $0.11B $2.65B 4.42%
2018-09-30 $-0.11B $2.52B -4.62%
2018-06-30 $-0.10B $2.40B -4.39%
2018-03-31 $-0.17B $2.31B -7.75%
2017-12-31 $-0.31B $2.30B -15.80%
2017-09-30 $-0.15B $2.37B -8.49%
2017-06-30 $-0.15B $1.64B -9.52%
2017-03-31 $-0.11B $1.61B -6.89%
2016-12-31 $0.10B $1.64B 7.29%
2016-09-30 $0.15B $1.54B 11.83%
2016-06-30 $0.07B $1.42B 6.55%
2016-03-31 $0.05B $1.10B 4.83%
2015-12-31 $0.01B $1.01B 0.64%
2015-09-30 $-0.09B $0.93B -9.77%
2015-06-30 $0.01B $0.93B 1.54%
2015-03-31 $-0.03B $0.86B -4.23%
2014-12-31 $-0.05B $0.80B -6.70%
2014-09-30 $-0.06B $0.79B -7.97%
2014-06-30 $-0.14B $0.68B -23.32%
2014-03-31 $-0.10B $0.67B -20.52%
2013-12-31 $-0.08B $0.63B -20.35%
2013-09-30 $-0.02B $0.36B -6.51%
2013-06-30 $-0.02B $0.33B -6.82%
2013-03-31 $-0.02B $0.33B -4.73%
2012-12-31 $-0.04B $0.33B -14.27%
2012-09-30 $-0.12B $0.30B -38.31%
2012-06-30 $-0.15B $0.31B -45.64%
2012-03-31 $-0.21B $0.29B -58.11%
2011-12-31 $-0.19B $0.33B -47.43%
2011-09-30 $-0.10B $0.37B -22.78%
2011-06-30 $-0.08B $0.42B -17.03%
2011-03-31 $-0.02B $0.46B -4.82%
2010-12-31 $-0.03B $0.49B -6.56%
2010-09-30 $-0.15B $0.47B -28.15%
2010-06-30 $-0.16B $0.49B -30.06%
2010-03-31 $-0.21B $0.50B -44.83%
2009-12-31 $-0.21B $0.71B -55.02%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $13.312B $4.241B
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $226.021B 16.87
Amgen (AMGN) United States $156.112B 13.98
Gilead Sciences (GILD) United States $139.892B 14.53
Vertex Pharmaceuticals (VRTX) United States $115.687B 0.00
Bristol Myers Squibb (BMY) United States $98.518B 6.60
GSK (GSK) United Kingdom $84.443B 10.10
CSL (CSLLY) Australia $76.467B 0.00
Regeneron Pharmaceuticals (REGN) United States $53.251B 12.93
Alnylam Pharmaceuticals (ALNY) United States $39.225B 0.00
Argenex SE (ARGX) Netherlands $35.777B 97.65
BioNTech SE (BNTX) Germany $26.080B 0.00
Biogen (BIIB) United States $19.507B 8.42
Royalty Pharma (RPRX) United States $18.992B 8.02
Genmab (GNMSF) Denmark $14.413B 14.74
Genmab (GMAB) Denmark $14.235B 15.97
Insmed (INSM) United States $13.409B 0.00
Illumina (ILMN) United States $13.085B 24.82
Exelixis (EXEL) United States $11.735B 19.92
BioMarin Pharmaceutical (BMRN) United States $10.864B 17.65
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Moderna (MRNA) United States $10.620B 0.00
Ascendis Pharma (ASND) Denmark $10.572B 0.00
Exact Sciences (EXAS) United States $10.351B 0.00
QIAGEN (QGEN) Netherlands $10.110B 19.67
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.925B 0.00
Blueprint Medicines (BPMC) United States $8.257B 0.00
Revolution Medicines (RVMD) United States $7.654B 0.00
Roivant Sciences (ROIV) United Kingdom $7.634B 0.00
Bio-Techne Corp (TECH) United States $7.633B 28.47
Repligen (RGEN) United States $7.208B 80.69
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.180B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.851B 6.60
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.685B 12.80
Legend Biotech (LEGN) United States $6.432B 0.00
TG Therapeutics (TGTX) United States $6.360B 166.92
Guardant Health (GH) United States $5.954B 0.00
Telix Pharmaceuticals (TLX) Australia $5.670B 0.00
Nuvalent (NUVL) United States $5.603B 0.00
Axsome Therapeutics (AXSM) United States $5.510B 0.00
Alkermes (ALKS) Ireland $5.229B 14.03
Zealand Pharma (ZLDPF) Denmark $5.051B 0.00
ADMA Biologics Inc (ADMA) United States $4.920B 36.80
Vaxcyte (PCVX) United States $4.772B 0.00
Avidity Biosciences (RNA) United States $4.368B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.333B 0.00
Akero Therapeutics (AKRO) United States $4.327B 0.00
Sarepta Therapeutics (SRPT) United States $4.227B 0.00
Zai Lab (ZLAB) China $4.205B 0.00
PTC Therapeutics (PTCT) United States $4.132B 7.19
Krystal Biotech (KRYS) United States $3.957B 30.50
Merus (MRUS) Netherlands $3.891B 0.00
Cytokinetics (CYTK) United States $3.858B 0.00
Arcellx (ACLX) United States $3.753B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.679B 32.32
CRISPR Therapeutics AG (CRSP) Switzerland $3.615B 0.00
SpringWorks Therapeutics (SWTX) United States $3.526B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.514B 0.00
Protagonist Therapeutics (PTGX) United States $3.371B 72.51
Scholar Rock Holding (SRRK) United States $3.250B 0.00
Alvotech (ALVO) Luxembourg $3.214B 18.38
Viking Therapeutics (VKTX) United States $3.126B 0.00
Kymera Therapeutics (KYMR) United States $3.101B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.001B 0.00
Metsera (MTSR) United States $2.888B 0.00
Immunovant (IMVT) United States $2.866B 0.00
ImmunityBio (IBRX) United States $2.780B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.676B 0.00
Ascentage Pharma Group - (AAPG) China $2.472B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.428B 0.00
Apellis Pharmaceuticals (APLS) United States $2.423B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.321B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.297B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.206B 0.00
Vericel (VCEL) United States $2.180B 1443.33
Bavarian Nordic (BVNRY) Denmark $2.168B 11.46
Denali Therapeutics (DNLI) United States $2.136B 0.00
CG Oncology (CGON) United States $2.051B 0.00
Ligand Pharmaceuticals (LGND) United States $2.045B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.044B 13.59
Agios Pharmaceuticals (AGIO) United States $1.988B 0.00
Certara (CERT) United States $1.908B 35.64
IDEAYA Biosciences (IDYA) United States $1.903B 0.00
Belite Bio (BLTE) United States $1.900B 0.00
Amicus Therapeutics (FOLD) United States $1.897B 205.33
NovoCure (NVCR) Jersey $1.895B 0.00
Twist Bioscience (TWST) United States $1.892B 0.00
Apogee Therapeutics (APGE) United States $1.887B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.871B 0.00
Beam Therapeutics (BEAM) United States $1.868B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.845B 0.00
Biohaven (BHVN) United States $1.739B 0.00
Disc Medicine (IRON) United States $1.732B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.713B 0.00
Edgewise Therapeutics (EWTX) United States $1.603B 0.00
Janux Therapeutics (JANX) United States $1.551B 0.00
Liquidia Technologies (LQDA) United States $1.551B 0.00
Adaptive Biotechnologies (ADPT) United States $1.533B 0.00
Mesoblast (MESO) Australia $1.507B 0.00
89BIO (ETNB) United States $1.496B 0.00
Vera Therapeutics (VERA) United States $1.448B 0.00
Celldex Therapeutics (CLDX) United States $1.417B 0.00
GRAIL (GRAL) United States $1.380B 0.00
Travere Therapeutics (TVTX) United States $1.360B 0.00
ANI Pharmaceuticals (ANIP) United States $1.342B 13.83
MannKind (MNKD) United States $1.331B 27.38
BGM Group (BGM) China $1.272B 0.00
Anbio Biotechnology (NNNN) Germany $1.233B 0.00
Dynavax Technologies (DVAX) United States $1.230B 73.14
Structure Therapeutics (GPCR) United States $1.212B 0.00
Novavax (NVAX) United States $1.207B 2.81
Pacira BioSciences (PCRX) United States $1.202B 11.44
Viridian Therapeutics (VRDN) United States $1.198B 0.00
WAVE Life Sciences (WVE) Singapore $1.113B 0.00
Arcus Biosciences (RCUS) United States $1.056B 0.00
Mineralys Therapeutics (MLYS) United States $1.051B 0.00
Spyre Therapeutics (SYRE) United States $1.023B 0.00
Niagen Bioscience (NAGE) United States $1.020B 143.89
Geron (GERN) United States $1.019B 0.00
CureVac (CVAC) Germany $0.989B 4.79
Syndax Pharmaceuticals (SNDX) United States $0.985B 0.00
Nurix Therapeutics (NRIX) United States $0.974B 0.00
MiMedx (MDXG) United States $0.959B 23.18
NeoGenomics (NEO) United States $0.955B 0.00
CorMedix Inc (CRMD) United States $0.948B 63.54
UniQure (QURE) Netherlands $0.946B 0.00
Praxis Precision Medicines (PRAX) United States $0.908B 0.00
LENZ Therapeutics (LENZ) United States $0.900B 0.00
Pharvaris (PHVS) Netherlands $0.877B 0.00
Zymeworks (ZYME) United States $0.877B 0.00
Oculis Holding AG (OCS) Switzerland $0.870B 0.00
Nuvation Bio (NUVB) United States $0.844B 0.00
Intellia Therapeutics (NTLA) United States $0.838B 0.00
Trevi Therapeutics (TRVI) United States $0.828B 0.00
Pharming Group (PHAR) Netherlands $0.807B 0.00
ArriVent BioPharma (AVBP) United States $0.805B 0.00
Replimune (REPL) United States $0.800B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Immunome (IMNM) United States $0.794B 0.00
Gyre Therapeutics (GYRE) United States $0.789B 210.25
Cogent Biosciences (COGT) United States $0.774B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Sionna Therapeutics (SION) United States $0.760B 0.00
Vir Biotechnology (VIR) United States $0.753B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.729B 0.00
AbCellera Biologics (ABCL) Canada $0.728B 0.00
Immatics (IMTX) Germany $0.726B 0.00
Anavex Life Sciences (AVXL) United States $0.706B 0.00
AnaptysBio (ANAB) United States $0.696B 0.00
Iovance Biotherapeutics (IOVA) United States $0.685B 0.00
Arbutus Biopharma (ABUS) United States $0.667B 0.00
Oric Pharmaceuticals (ORIC) United States $0.663B 0.00
GH Research (GHRS) Ireland $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Sana Biotechnology (SANA) United States $0.640B 0.00
Bicara Therapeutics (BCAX) United States $0.627B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.623B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.623B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.615B 0.00
Keros Therapeutics (KROS) United States $0.611B 0.00
Stoke Therapeutics (STOK) United States $0.608B 14.10
Upstream Bio (UPB) United States $0.606B 0.00
Dianthus Therapeutics (DNTH) United States $0.606B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.592B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.589B 0.00
Kura Oncology (KURA) United States $0.583B 0.00
Maze Therapeutics (MAZE) United States $0.566B 0.00
Tyra Biosciences (TYRA) United States $0.560B 0.00
Arvinas (ARVN) United States $0.550B 0.00
Cullinan Therapeutics (CGEM) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Abivax SA (ABVX) France $0.520B 0.00
Castle Biosciences (CSTL) United States $0.508B 34.51
Celcuity (CELC) United States $0.494B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
MeiraGTx Holdings (MGTX) United States $0.482B 0.00
REGENXBIO (RGNX) United States $0.482B 0.00
ATyr Pharma (ATYR) United States $0.479B 0.00
Fortrea Holdings (FTRE) United States $0.478B 13.20
Myriad Genetics (MYGN) United States $0.469B 0.00
Zenas BioPharma (ZBIO) United States $0.465B 0.00
Rapport Therapeutics (RAPP) United States $0.462B 0.00
Tango Therapeutics (TNGX) United States $0.462B 0.00
PureTech Health (PRTC) United States $0.456B 0.00
Septerna (SEPN) United States $0.455B 0.00
Erasca (ERAS) United States $0.453B 0.00
Eton Pharmaceuticals (ETON) United States $0.452B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.444B 0.00
Precigen (PGEN) United States $0.443B 0.00
Cytek Biosciences (CTKB) United States $0.436B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.436B 0.00
Tectonic Therapeutic (TECX) United States $0.431B 0.00
Sage Therapeutics (SAGE) United States $0.429B 0.00
Benitec Biopharma (BNTC) United States $0.420B 0.00
Humacyte (HUMA) United States $0.402B 0.00
Kamada (KMDA) Israel $0.394B 23.62
Northwest Biotherapeutics (NWBO) United States $0.392B 0.00
Fulcrum Therapeutics (FULC) United States $0.391B 0.00
ITeos Therapeutics (ITOS) United States $0.389B 0.00
Absci (ABSI) United States $0.387B 0.00
MBX Biosciences (MBX) United States $0.380B 0.00
Rezolute (RZLT) United States $0.379B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.364B 0.00
Emergent Biosolutions (EBS) United States $0.360B 0.00
Verastem (VSTM) United States $0.353B 0.00
Solid Biosciences (SLDB) United States $0.352B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.347B 0.00
Compass Therapeutics (CMPX) United States $0.346B 0.00
Inventiva S.A (IVA) France $0.345B 0.00
Abeona Therapeutics (ABEO) United States $0.345B 0.00
Urogen Pharma (URGN) United States $0.340B 0.00
Astria Therapeutics (ATXS) United States $0.338B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.327B 0.00
Aura Biosciences (AURA) United States $0.327B 0.00
Terns Pharmaceuticals (TERN) United States $0.323B 0.00
Alpha Teknova (TKNO) United States $0.317B 0.00
Cidara Therapeutics (CDTX) United States $0.316B 0.00
Entrada Therapeutics (TRDA) United States $0.316B 10.27
Neurogene (NGNE) United States $0.311B 0.00
Allogene Therapeutics (ALLO) United States $0.311B 0.00
Ocugen (OCGN) United States $0.310B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.308B 62.62
Olema Pharmaceuticals (OLMA) United States $0.305B 0.00
Candel Therapeutics (CADL) United States $0.303B 0.00
Gossamer Bio (GOSS) United States $0.302B 0.00
XOMA Royalty (XOMA) United States $0.302B 0.00
Prothena (PRTA) Ireland $0.291B 0.00
Cartesian Therapeutics (RNAC) United States $0.286B 0.00
Annexon (ANNX) United States $0.285B 0.00
Palvella Therapeutics (PVLA) United States $0.281B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.279B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.277B 0.00
Atea Pharmaceuticals (AVIR) United States $0.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.272B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
Tvardi Therapeutics (TVRD) United States $0.267B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.267B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Amarin (AMRN) Ireland $0.263B 0.00
Semper Paratus Acquisition (TVGN) United States $0.263B 0.00
Cardiff Oncology (CRDF) United States $0.258B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Aardvark Therapeutics (AARD) United States $0.256B 0.00
Lifecore Biomedical (LFCR) United States $0.254B 0.00
DBV Technologies S.A (DBVT) France $0.250B 0.00
Foghorn Therapeutics (FHTX) United States $0.249B 0.00
Third Harmonic Bio (THRD) United States $0.239B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.239B 0.00
BioStem Technologies (BSEM) $0.237B 9.64
Adherex Technologies (FENC) United States $0.233B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
MaxCyte (MXCT) United States $0.229B 0.00
Design Therapeutics (DSGN) United States $0.228B 0.00
Monopar Therapeutics (MNPR) United States $0.227B 0.00
Kodiak Sciences (KOD) United States $0.223B 0.00
Prime Medicine (PRME) United States $0.222B 0.00
ScPharmaceuticals (SCPH) United States $0.222B 0.00
CARGO Therapeutics (CRGX) United States $0.219B 0.00
Instil Bio (TIL) United States $0.216B 0.00
Adocia (ADOCY) France $0.213B 0.00
CytomX Therapeutics (CTMX) United States $0.213B 5.50
AC Immune (ACIU) Switzerland $0.205B 0.00
Inhibrx Biosciences (INBX) United States $0.202B 0.12
GENFIT S.A (GNFT) France $0.201B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.201B 0.00
I-Mab (IMAB) United States $0.200B 0.00
Innate Pharma S.A (IPHA) France $0.200B 0.00
Codexis (CDXS) United States $0.196B 0.00
Voyager Therapeutics (VYGR) United States $0.196B 0.00
Bright Minds Biosciences (DRUG) United States $0.194B 0.00
EnGene Holdings (ENGN) Canada $0.193B 0.00
Nuvectis Pharma (NVCT) United States $0.185B 0.00
Puma Biotechnology (PBYI) United States $0.185B 4.83
Eledon Pharmaceuticals (ELDN) United States $0.184B 0.00
Fate Therapeutics (FATE) United States $0.183B 0.00
DiaMedica Therapeutics (DMAC) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.176B 0.00
INmune Bio (INMB) United States $0.175B 0.00
Ventyx Biosciences (VTYX) United States $0.175B 0.00
Sagimet Biosciences (SGMT) United States $0.171B 0.00
Alumis (ALMS) United States $0.170B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.167B 0.00
Neumora Therapeutics (NMRA) United States $0.165B 0.00
Agenus (AGEN) United States $0.163B 0.00
Anika Therapeutics (ANIK) United States $0.163B 0.00
Galena Biopharma (SLS) United States $0.161B 0.00
Editas Medicine (EDIT) United States $0.160B 0.00
BioAge Labs (BIOA) United States $0.160B 0.00
Compugen (CGEN) Israel $0.155B 0.00
Rapt Therapeutics (RAPT) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.153B 0.00
23andMe Holding (MEHCQ) United States $0.152B 0.00
Alpha Cognition (ACOG) Canada $0.150B 0.00
Alector (ALEC) United States $0.149B 0.00
Black Diamond Therapeutics (BDTX) United States $0.147B 43.00
Kyverna Therapeutics (KYTX) United States $0.147B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.141B 0.00
Spero Therapeutics (SPRO) United States $0.140B 0.00
Nkarta (NKTX) United States $0.135B 0.00
Seer (SEER) United States $0.134B 0.00
Greenwich LifeSciences (GLSI) United States $0.129B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.127B 0.00
Cabaletta Bio (CABA) United States $0.126B 0.00
Elicio Therapeutics (ELTX) United States $0.125B 0.00
Sangamo Therapeutics (SGMO) United States $0.124B 0.00
Contineum Therapeutics (CTNM) United States $0.123B 0.00
C4 Therapeutics (CCCC) United States $0.123B 0.00
TuHURA Biosciences (HURA) United States $0.123B 0.00
Invivyd (IVVD) United States $0.119B 0.00
Theratechnologies (THTX) Canada $0.119B 0.00
Caribou Biosciences (CRBU) United States $0.117B 0.00
BioHarvest Sciences (BHST) Canada $0.114B 0.00
EXoZymes (EXOZ) United States $0.112B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.109B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.109B 0.00
IO Biotech (IOBT) Denmark $0.105B 0.00
Tenaya Therapeutics (TNYA) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.102B 0.00
Senti Biosciences (SNTI) United States $0.100B 0.00
Pliant Therapeutics (PLRX) United States $0.100B 0.00
HilleVax (HLVX) United States $0.100B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Nautilus Biotechnology (NAUT) United States $0.097B 0.00
Genelux (GNLX) United States $0.097B 0.00
Coherus BioSciences (CHRS) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.094B 0.00
Climb Bio (CLYM) United States $0.094B 0.00
Adagene (ADAG) China $0.094B 0.00
Biomea Fusion (BMEA) United States $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Jasper Therapeutics (JSPR) United States $0.090B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.089B 0.00
XBiotech (XBIT) United States $0.088B 0.00
Whitehawk Therapeutics (WHWK) United States $0.088B 0.00
Zura Bio (ZURA) United States $0.086B 0.00
Inovio Pharmaceuticals (INO) United States $0.083B 0.00
IGM Biosciences (IGMS) United States $0.079B 0.00
Cellectis S.A (CLLS) France $0.078B 0.00
Elutia (ELUT) United States $0.078B 0.00
PDS Biotechnology (PDSB) United States $0.077B 0.00
Immuneering (IMRX) United States $0.077B 0.00
Immunic (IMUX) United States $0.076B 0.00
Skye Bioscience (SKYE) United States $0.075B 0.00
Citius Oncology (CTOR) United States $0.075B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.075B 0.00
TELA Bio (TELA) United States $0.075B 0.00
Forte Biosciences (FBRX) United States $0.075B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.073B 0.00
Seres Therapeutics (MCRB) United States $0.072B 0.00
Sutro Biopharma (STRO) United States $0.072B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
MediciNova (MNOV) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
Ikena Oncology (IKNA) United States $0.069B 0.00
Exicure (XCUR) United States $0.068B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Immix Biopharma (IMMX) United States $0.066B 0.00
ZIVO Bioscience (ZIVO) United States $0.066B 0.00
OKYO Pharma (OKYO) $0.064B 0.00
Oncobiologics (OTLK) United States $0.064B 0.00
Werewolf Therapeutics (HOWL) United States $0.064B 0.00
Repare Therapeutics (RPTX) Canada $0.063B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
Annovis Bio (ANVS) United States $0.063B 0.00
Opus Genetics (IRD) United States $0.062B 0.00
Kalaris Therapeutics (KLRS) United States $0.062B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Adlai Nortye (ANL) Cayman Islands $0.061B 0.00
Precision BioSciences (DTIL) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Adverum Biotechnologies (ADVM) United States $0.059B 0.00
Akoya Biosciences (AKYA) United States $0.058B 0.00
InflaRx (IFRX) Germany $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.055B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
Quince Therapeutics (QNCX) United States $0.053B 0.00
Renovaro (RENB) United States $0.053B 0.00
Applied Therapeutics (APLT) United States $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
Artiva Biotherapeutics (ARTV) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.051B 0.00
Celularity (CELU) United States $0.050B 0.00
PepGen (PEPG) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Mersana Therapeutics (MRSN) United States $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.044B 0.00
Rein Therapeutics (RNTX) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Connect Biopharma Holdings (CNTB) United States $0.044B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.042B 0.00
Quantum Biopharma (QNTM) Canada $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
CAMP4 Therapeutics (CAMP) United States $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Clene (CLNN) United States $0.038B 0.00
Medicus Pharma (MDCX) United States $0.037B 0.00
Pluri (PLUR) Israel $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
FibroBiologics (FBLG) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.031B 0.00
Oncolytics Biotech (ONCY) Canada $0.031B 0.00
ALX Oncology Holdings (ALXO) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
Generation Bio (GBIO) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
BioAtla (BCAB) United States $0.028B 0.00
Vor Biopharma (VOR) $0.028B 0.00
KALA BIO (KALA) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Passage Bio (PASG) United States $0.026B 0.00
ABVC BioPharma (ABVC) United States $0.026B 0.00
Imunon (IMNN) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
X4 Pharmaceuticals (XFOR) United States $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.024B 0.00
CalciMedica (CALC) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.023B 0.00
Ovid Therapeutics (OVID) United States $0.023B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.022B 0.00
Femasys (FEMY) United States $0.020B 0.00
Advanced Biomed (ADVB) United States $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Elevation Oncology (ELEV) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
Longeveron (LGVN) United States $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Rallybio (RLYB) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Eyenovia (EYEN) United States $0.014B 0.00
Athira Pharma (ATHA) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
HCW Biologics (HCWB) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00